These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 9553925)

  • 1. Effects of cyclosporin A on mycelial transformation of Candida albicans cells in human serum.
    Krajewska-Kułak E; Niczyporuk W
    J Eur Acad Dermatol Venereol; 1998 Mar; 10(2):191-2. PubMed ID: 9553925
    [No Abstract]   [Full Text] [Related]  

  • 2. Ultrastructural changes of Candida albicans under influence of cyclosporin A.
    Krajewska-Kułak E; Niczyporuk W; Szynaka B
    Rocz Akad Med Bialymst; 1997; 42 Suppl 2():208-11. PubMed ID: 9646704
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The in-vitro action of immunodepressants on the morphological properties of Candida albicans fungi].
    Pakhomova EN
    Zh Mikrobiol Epidemiol Immunobiol; 1994; (2):24-7. PubMed ID: 8017120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Designed Tryptophan- and Lysine/Arginine-Rich Antimicrobial Peptide with Therapeutic Potential for Clinical Antibiotic-Resistant Candida albicans Vaginitis.
    Jin L; Bai X; Luan N; Yao H; Zhang Z; Liu W; Chen Y; Yan X; Rong M; Lai R; Lu Q
    J Med Chem; 2016 Mar; 59(5):1791-9. PubMed ID: 26881456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calcineurin promotes infection of the cornea by Candida albicans and can be targeted to enhance fluconazole therapy.
    Onyewu C; Afshari NA; Heitman J
    Antimicrob Agents Chemother; 2006 Nov; 50(11):3963-5. PubMed ID: 16923949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The calcineruin inhibitor cyclosporine a synergistically enhances the susceptibility of Candida albicans biofilms to fluconazole by multiple mechanisms.
    Jia W; Zhang H; Li C; Li G; Liu X; Wei J
    BMC Microbiol; 2016 Jun; 16(1):113. PubMed ID: 27316338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amphotericin B-resistant Candida albicans.
    Hopfer RL
    J Infect Dis; 1992 Nov; 166(5):1196-8. PubMed ID: 1402037
    [No Abstract]   [Full Text] [Related]  

  • 8. Lack of correlation of 24- vs. 48-h itraconazole minimum inhibitory concentrations with microbiological and survival outcomes in a guinea pig model of disseminated candidiasis.
    Odabasi Z; Paetznick VL; Rodriguez JR; Chen E; Rex JH; Leitz GJ; Ostrosky-Zeichner L
    Mycoses; 2010 Sep; 53(5):438-42. PubMed ID: 19500259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influences of immunosuppressive agents, FK506 and cyclosporin on systemic Candida albicans infection in mice.
    Ito E; Tanaka Y
    Mycopathologia; 1997; 138(2):57-64. PubMed ID: 9433807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The synergy of honokiol and fluconazole against clinical isolates of azole-resistant Candida albicans.
    Jin J; Guo N; Zhang J; Ding Y; Tang X; Liang J; Li L; Deng X; Yu L
    Lett Appl Microbiol; 2010 Sep; 51(3):351-7. PubMed ID: 20681969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antifungal activities of two new azasordarins, GW471552 and GW471558, in experimental models of oral and vulvovaginal candidiasis in immunosuppressed rats.
    Martinez A; Ferrer S; Santos I; Jimenez E; Sparrowe J; Regadera J; De Las Heras FG; Gargallo-Viola D
    Antimicrob Agents Chemother; 2001 Dec; 45(12):3304-9. PubMed ID: 11709301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of itraconazole on the process of mycelial transformation of Candida albicans cells in human serum].
    Gwiezdziński Z; Urbanowski S; Nierebińska E
    Med Dosw Mikrobiol; 1989; 41(3-4):202-5. PubMed ID: 2561811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro and in vivo candicidal activities of 2-(p-n-hexylphenylamino)-1,3-thiazoline.
    Baumann RJ; Mayer GD; Fite LD; Gill LM; Harrison BL
    Chemotherapy; 1991; 37(3):157-65. PubMed ID: 1889303
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergistic anti-candida activities of lactoferrin and the lactoperoxidase system.
    Nakano M; Suzuki M; Wakabayashi H; Hayama K; Yamauchi K; Abe F; Abe S
    Drug Discov Ther; 2019; 13(1):28-33. PubMed ID: 30880319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclosporine A decreases the fluconazole minimum inhibitory concentration of Candida albicans clinical isolates but not biofilm formation and cell growth.
    Wibawa T; Nurrokhman ; Baly I; Daeli PR; Kartasasmita G; Wijayanti N
    Trop Biomed; 2015 Mar; 32(1):176-82. PubMed ID: 25801268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Derivation of an in vivo drug exposure breakpoint for flucytosine against Candida albicans and Impact of the MIC, growth rate, and resistance genotype on the antifungal effect.
    Hope WW; Warn PA; Sharp A; Howard S; Kasai M; Louie A; Walsh TJ; Drusano GL; Denning DW
    Antimicrob Agents Chemother; 2006 Nov; 50(11):3680-8. PubMed ID: 16954320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Microbiological efficacy of a one-day treatment with triazole antimycotic I traconazole in mycotic colpitis].
    Andreeva P; Savova D; Konovalova M; Unakova M; Shterev A
    Akush Ginekol (Sofiia); 2014; 53(7):9-12. PubMed ID: 25675616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulatory effect of the lectin-binding component, added to gel, on adhesion of yeast-like Candida fungi in vivo.
    Anokhina IV; Kravtsov EG; Sachivkina NP; Yashina NV; Dalin MV; Semkina OA
    Bull Exp Biol Med; 2011 Nov; 152(1):86-9. PubMed ID: 22803048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of caspofungin against Candida guilliermondii and Candida parapsilosis.
    Barchiesi F; Spreghini E; Tomassetti S; Della Vittoria A; Arzeni D; Manso E; Scalise G
    Antimicrob Agents Chemother; 2006 Aug; 50(8):2719-27. PubMed ID: 16870764
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced fluconazole susceptibility of Candida albicans isolates in women with recurrent vulvovaginal candidiasis: effects of long-term fluconazole therapy.
    Shahid Z; Sobel JD
    Diagn Microbiol Infect Dis; 2009 Jul; 64(3):354-6. PubMed ID: 19501794
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.